By Sammi Bjelland
Senate passes a bill today to cut back on some drugs, and expand others.
The Food and Drug Administration and Safety Innovation Act includes two provisions written by Minnesota Senator Amy Klobuchar.
Senator Klobuchar was the chief sponsor and author of two key provisions in the bill.
One of these provisions will force drug manufacturers to warn the FDA when they are running low on drug supplies.
Sen. Amy Klobuchar says, "What we found is that when the FDA has that information, it's incredibly helpful because they can find alternative suppliers. Either in the U.S. or in safe places like Canada. And it actually decreases the drug shortages."
The other provision focuses on cracking down on synthetic drug use, like 2c-e that led to the death of a Minnesota teen.
Senator Klobuchar says the key to stopping these drug makers is to stay one step ahead.
Sen. Klobuchar says, "the next step is to look at the statute, called the Analog Statute, that's used when you have a drug that's a little different but very similar. And make it easier so prosecutors can prove that up."
Klobuchar will now work on making this statue a reality to stop the production of synthetic drugs.